Member area login
You don't have or don't remember the password!
Click Here
Maria Stella Graziani

Deputy Director
Martina Zaninotto

Associate Editors
Ferruccio Ceriotti
Davide Giavarina
Bruna Lo Sasso
Giampaolo Merlini
Martina Montagnana
Andrea Mosca
Paola Pezzati
Rossella Tomaiuolo
Matteo Vidali

EIC Assistant
Francesco Busardò

International Advisory Board Khosrow Adeli Canada
Sergio Bernardini Italy
Marcello Ciaccio Italy
Eleftherios Diamandis Canada
Philippe Gillery France
Kjell Grankvist Sweden
Hans Jacobs The Netherlands
Eric Kilpatrick UK
Magdalena Krintus Poland
Giuseppe Lippi Italy
Mario Plebani Italy
Sverre Sandberg Norway
Ana-Maria Simundic Croatia
Tommaso Trenti Italy
Cas Weykamp The Netherlands
Maria Willrich USA
Paul Yip Canada

Biomedia srl
Via L. Temolo 4, 20126 Milano

Responsible Editor
Giuseppe Agosta

Editorial Secretary
Chiara Riva
Biomedia srl
Via L. Temolo 4, 20126 Milano
Tel. 0245498282


ISSN print: 0393 – 0564
ISSN digital: 0392- 7091

Articoli con TAG: cannabis light

Cannabis e cannabinoidi naturali: focus su aspetti legislativi, clinici e di medicina di laboratorio
Cannabis and natural cannabinoids: focus on legislative, clinical and laboratory medicine aspects
<p>&nbsp;</p><p style="text-align:justify"><span style="font-size:9.0pt">The use of Cannabis and its derivatives is increasingly at the center of intense political debates related to regulation or prohibition. Beyond the political or ideological debates, a scientifically based information policy is however necessary to understand the differences between Cannabis used for recreational purposes, light Cannabis that can be legally sold, and Cannabis administered for therapeutic purposes, with a special focus to the analytical methods that can be utilized to differentiate the different types of Cannabis. Regarding the different properties, considered that the differentiation between the various types of Cannabis, (recreational, light or medical) is essential for legal purposes, the role played by the analytical toxicology laboratories is crucial. A number of studies with light and medical Cannabis have illustrated the possible use of Cannabidiol (CBD) as a possible biomarker to identify the type of Cannabis, since CBD is predominant in light Cannabis; the ratio of CBD to &Delta;9-tetrahydrocannabinol (THC), the only cannabinoid with psychotropic effects, has been suggested to be of particular relevance.&nbsp;</span><span style="font-size:9pt">This review aims to analyze the current legislative, medical and laboratory medicine aspects connected to Cannabis in Italy, by focusing on the legislation currently in force and on the role of the toxicology laboratory in differentiating the different types of Cannabis.</span></p>
Biochimica Clinica ; 46(3) 190-200
Rassegne - Reviews